Innate immune evasion revealed in a colorectal zebrafish xenograft model.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
19 02 2021
Historique:
received: 06 03 2020
accepted: 26 01 2021
entrez: 20 2 2021
pubmed: 21 2 2021
medline: 12 3 2021
Statut: epublish

Résumé

Cancer immunoediting is a dynamic process of crosstalk between tumor cells and the immune system. Herein, we explore the fast zebrafish xenograft model to investigate the innate immune contribution to this process. Using multiple breast and colorectal cancer cell lines and zAvatars, we find that some are cleared (regressors) while others engraft (progressors) in zebrafish xenografts. We focus on two human colorectal cancer cells derived from the same patient that show contrasting engraftment/clearance profiles. Using polyclonal xenografts to mimic intra-tumor heterogeneity, we demonstrate that SW620_progressors can block clearance of SW480_regressors. SW480_regressors recruit macrophages and neutrophils more efficiently than SW620_progressors; SW620_progressors however, modulate macrophages towards a pro-tumoral phenotype. Genetic and chemical suppression of myeloid cells indicates that macrophages and neutrophils play a crucial role in clearance. Single-cell-transcriptome analysis shows a fast subclonal selection, with clearance of regressor subclones associated with IFN/Notch signaling and escaper-expanded subclones with enrichment of IL10 pathway. Overall, our work opens the possibility of using zebrafish xenografts as living biomarkers of the tumor microenvironment.

Identifiants

pubmed: 33608544
doi: 10.1038/s41467-021-21421-y
pii: 10.1038/s41467-021-21421-y
pmc: PMC7895829
doi:

Substances chimiques

Homeodomain Proteins 0
RAG-1 protein 128559-51-3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1156

Références

Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331, 1565–1570 (2011).
pubmed: 21436444 doi: 10.1126/science.1203486
Liu, Y. & Cao, X. Immunosuppressive cells in tumor immune escape and metastasis. J. Mol. Med. 94, 509–522 (2016).
pubmed: 26689709 doi: 10.1007/s00109-015-1376-x
Cortez-Retamozo, V. et al. Origins of tumor-associated macrophages and neutrophils. Proc. Natl Acad. Sci. USA 109, 2491–2496 (2012).
pubmed: 22308361 doi: 10.1073/pnas.1113744109 pmcid: 3289379
Liu, Y. & Zeng, G. Cancer and innate immune system interactions: translational potentials for cancer immunotherapy. J. Immunother. 35, 299–308 (2012).
pubmed: 22495387 pmcid: 3331796 doi: 10.1097/CJI.0b013e3182518e83
Gentles, A. J. et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21, 938–945 (2015).
pubmed: 26193342 pmcid: 4852857 doi: 10.1038/nm.3909
Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887–904. (2018).
pubmed: 30361552 doi: 10.1038/nrd.2018.169
Van Overmeire, E., Laoui, D., Keirsse, J., Van Ginderachter, J. A. & Sarukhan, A. Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. Front. Immunol. 5(MAR), 1–16 (2014).
Gajewski, T. F., Schreiber, H. & Fu, Y.-X. Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14, 1014 (2013).
pubmed: 24048123 pmcid: 4118725 doi: 10.1038/ni.2703
White, R., Rose, K. & Zon, L. Zebrafish cancer: the state of the art and the path forward. Nat. Rev. Cancer 13, 624–636 (2013).
pubmed: 23969693 pmcid: 6040891 doi: 10.1038/nrc3589
Roh-Johnson, M. et al. Macrophage-dependent cytoplasmic transfer during melanoma invasion in vivo. Dev. Cell. 43, 549–562.e6 (2017).
pubmed: 29207258 pmcid: 5728704 doi: 10.1016/j.devcel.2017.11.003
Chapman, A. et al. Heterogeneous tumor subpopulations cooperate to drive invasion. Cell Rep. 8, 688–695 (2014).
pubmed: 25066122 pmcid: 4542310 doi: 10.1016/j.celrep.2014.06.045
Wyatt, R. A., Trieu, N. P. V. & Crawford, B. D. Zebrafish xenograft: an evolutionary experiment in tumour biology. Genes 8 https://doi.org/10.3390/genes8090220 (2017).
Lam, S. et al. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat. Biotechnol. 24, 73–75 (2006).
pubmed: 16327811 doi: 10.1038/nbt1169
Renshaw, S. A. & Trede, N. S. A model 450 million years in the making: zebrafish and vertebrate immunity. Dis. Model Mech. 5, 38–47 (2012).
pubmed: 22228790 pmcid: 3255542 doi: 10.1242/dmm.007138
Fior, R. et al. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc. Natl Acad. Sci. USA 114, 201618389 (2017).
doi: 10.1073/pnas.1618389114
O’Sullivan, T. et al. Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J. Exp. Med. 209, 1869–1882 (2012).
pubmed: 22927549 pmcid: 3457735 doi: 10.1084/jem.20112738
Leibovitz, A. et al. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36, 4562–4569 (1976).
pubmed: 1000501
Hewitt, R. E. et al. Validation of a model of colon cancer progression. J. Pathol. 192, 446–454 (2000).
pubmed: 11113861 doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
doi: 10.1073/pnas.0506580102 pubmed: 16199517 pmcid: 1239896
Blomberg, O. S., Spagnuolo, L. & de Visser, K. E. Immune regulation of metastasis: mechanistic insights and therapeutic opportunities. Dis. Model Mech. 11, dmm036236 (2018).
pubmed: 30355585 pmcid: 6215427 doi: 10.1242/dmm.036236
Oh, B. Y. et al. Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patients. Oncotarget 6, 16059–16068 (2015).
pubmed: 25965827 pmcid: 4599256 doi: 10.18632/oncotarget.3863
Travnickova, J. et al. Primitive macrophages control HSPC mobilization and definitive haematopoiesis. Nat. Commun. 6, 1–9 (2015).
doi: 10.1038/ncomms7227
Renshaw, S. A. et al. A transgenic zebrafish model of neutrophilic inflammation. Blood 108, 3976–3978 (2006).
pubmed: 16926288 doi: 10.1182/blood-2006-05-024075
Nguyen-Chi, M. et al. Identification of polarized macrophage subsets in zebrafish. Elife 4, 1–14 (2015).
doi: 10.7554/eLife.07288
Galli, S. J., Borregaard, N. & Wynn, T. A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Publ. Gr. 12, 1035–1044 (2011).
Jin, H. et al. Definitive hematopoietic stem/progenitor cells manifest distinct differentiation output in the zebrafish VDA and PBI. Development 136, 1397 (2009).
pmcid: 3266480 doi: 10.1242/dev.036780
Parichy, D. M., Ransom, D. G., Paw, B., Zon, L. I. & Johnson, S. L. An orthologue of the kit-related gene fms is required for development of neural crest-derived xanthophores and a subpopulation of adult melanocytes in the zebrafish, Danio rerio. Development 127, 3031–3044 (2000).
pubmed: 10862741 doi: 10.1242/dev.127.14.3031
Loyher, P. L. et al. Macrophages of distinct origins contribute to tumor development in the lung. J. Exp. Med. 215, 1–18 (2018).
doi: 10.1084/jem.20180534
Bowman, R. L. et al. Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies. Cell Rep. 17, 2445–2459 (2016).
pubmed: 27840052 pmcid: 5450644 doi: 10.1016/j.celrep.2016.10.052
Zhu, Y. et al. Correction: Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression. Immunity 47, 597 (2017).
Herbomel, P., Thisse, B. & Thisse, C. Zebrafish early macrophages colonize cephalic mesenchyme and developing brain, retina, and epidermis through a M-CSF receptor-dependent invasive process. Dev. Biol. 238, 274–288 (2001).
pubmed: 11784010 doi: 10.1006/dbio.2001.0393
Morales, R. A. & Allende, M. L. Peripheral macrophages promote tissue regeneration in zebrafish by fine-tuning the inflammatory response. Front. Immunol. 10, 1–14 (2019).
doi: 10.3389/fimmu.2019.00253
Pagan, A. J. et al. Myeloid growth factors promote resistance to mycobacterial infection by curtailing granuloma necrosis through macrophage replenishment. Cell Host Microbe 18, 15–26 (2015).
pubmed: 26159717 pmcid: 4509513 doi: 10.1016/j.chom.2015.06.008
Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869–877 (1992).
pubmed: 1547488 doi: 10.1016/0092-8674(92)90030-G
Muraro, M. J. et al. A single-cell transcriptome atlas of the human pancreas. Cell Syst. 3, 385–394.e3 (2016).
pubmed: 27693023 pmcid: 5092539 doi: 10.1016/j.cels.2016.09.002
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744 doi: 10.1038/nbt.4096
Mclnnes, L., Healy, J., Saul, N. & GroBBerger, L. UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).
doi: 10.21105/joss.00861
Bazan, J. F. et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640–644 (1997).
pubmed: 9024663 doi: 10.1038/385640a0
Schumacher, C., Clark-Lewis, I., Baggiolini, M. & Moser, B. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc. Natl Acad. Sci. USA 89, 10542 LP–10510546 (1992).
doi: 10.1073/pnas.89.21.10542
Sadanandam, A. et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med. 19, 619–625 (2013).
pubmed: 23584089 pmcid: 3774607 doi: 10.1038/nm.3175
Crosnier, C., Stamataki, D. & Lewis, J. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat. Rev. Genet. 7, 349–359 (2006).
pubmed: 16619050 doi: 10.1038/nrg1840
Bray, S. J. Notch signalling in context. Nat. Rev. Mol. Cell Biol. 17, 722–735 (2016).
pubmed: 27507209 doi: 10.1038/nrm.2016.94
Yan, K. S. et al. Intestinal enteroendocrine lineage cells possess homeostatic and injury-inducible stem cell activity. Cell. Stem Cell. 21, 78–90.e6 (2017).
pubmed: 28686870 pmcid: 5642297 doi: 10.1016/j.stem.2017.06.014
Baulies, A., Angelis, N. & Li, V. S. W. Hallmarks of intestinal stem cells. Development 147, dev182675 (2020).
pubmed: 32747330 doi: 10.1242/dev.182675
Muñoz, J. et al. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers. EMBO J. 31, 3079–3091 (2012).
pubmed: 22692129 pmcid: 3400017 doi: 10.1038/emboj.2012.166
Smyth, M. J., Dunn, G. P. & Schreiber, R. D. in Cancer Immunotherapy Vol. 90, 1–50 (Academic Press, 2006).
Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137–148 (2004).
pubmed: 15308095 doi: 10.1016/j.immuni.2004.07.017
Zhou, Q. et al. The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J. Transl. Med. 8, 1–9 (2010).
doi: 10.1186/1479-5876-8-13
Forssell, J. et al. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin. Cancer Res. 13, 1472–1479 (2007).
pubmed: 17332291 doi: 10.1158/1078-0432.CCR-06-2073
Galdiero, M. R. et al. Occurrence and significance of tumor-Associated neutrophils in patients with colorectal cancer. Int. J. Cancer 139, 446–456 (2016).
pubmed: 26939802 doi: 10.1002/ijc.30076
Wikberg, M. L. et al. Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer. Hum. Pathol. 68, 193–202 (2017).
pubmed: 28882699 doi: 10.1016/j.humpath.2017.08.028
Edin, S., Wikberg, M. L., Oldenborg, P. A. & Palmqvist, R. Macrophages: Good guys in colorectal cancer. Oncoimmunology 2, 2–4 (2013).
doi: 10.4161/onci.23038
Guo, Q. et al. New mechanisms of tumor-associated macrophages on promoting tumor progression: recent research advances and potential targets for tumor immunotherapy. J. Immunol. Res. 2016 https://doi.org/10.1155/2016/9720912 (2016).
Ålgars, A. et al. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int. J. Cancer 131, 864–873 (2012).
pubmed: 21952788 doi: 10.1002/ijc.26457
Edin, S. et al. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS ONE. 7, https://doi.org/10.1371/journal.pone.0047045 (2012).
Schneemann, M. & Schoeden, G. Macrophage biology and immunology: man is not a mouse. J. Leukoc. Biol. 81, 579–579 (2007).
pubmed: 17332373 doi: 10.1189/jlb.1106702
Pinto, M. L. et al. The two faces of tumor-associated macrophages and their clinical significance in colorectal cancer. Front. Immunol. 10, 1–12 (2019).
doi: 10.3389/fimmu.2019.01875
Fridlender, Z. G. et al. Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN. Cancer Cell. 16, 183–194 (2009).
pubmed: 19732719 pmcid: 2754404 doi: 10.1016/j.ccr.2009.06.017
DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369–382 (2019).
pubmed: 30718830 pmcid: 7339861 doi: 10.1038/s41577-019-0127-6
Kim, J., Bae, J. & Tam, M. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016 https://doi.org/10.1155/2016/6058147 (2016).
Stoletov, K., Montel, V., Lester, R. D., Gonias, S. L. & Klemke, R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc. Natl Acad. Sci. USA 104, 17406–17411 (2007).
pubmed: 17954920 doi: 10.1073/pnas.0703446104 pmcid: 2077269
Zhao, C. et al. A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors. PLoS ONE 6, 1–9 (2011).
Costa, B. et al. Developments in zebrafish avatars as radiotherapy sensitivity reporters—towards personalized medicine. EBioMedicine 51, 1–12 (2020).
doi: 10.1016/j.ebiom.2019.11.039
Leggett, R. M., Ramirez-Gonzalez, R. H., Clavijo, B. J., Waite, D. & Davey, R. P. Sequencing quality assessment tools to enable data-driven informatics for high throughput genomics. Front Genet. 4, 1–5 (2013).
doi: 10.3389/fgene.2013.00288
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
pubmed: 24695404 pmcid: 4103590 doi: 10.1093/bioinformatics/btu170
Patro, R. et al. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference. Nat. Methods 14, 417–419 (2017).
Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Research. 4, 1–22 (2016).
doi: 10.12688/f1000research.7563.2
Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739–1740 (2011).
pubmed: 21546393 pmcid: 3106198 doi: 10.1093/bioinformatics/btr260
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
pubmed: 19451168 pmcid: 2705234 doi: 10.1093/bioinformatics/btp324

Auteurs

Vanda Póvoa (V)

Champalimaud Centre for the Unknown, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.

Cátia Rebelo de Almeida (C)

Champalimaud Centre for the Unknown, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.

Mariana Maia-Gil (M)

Champalimaud Centre for the Unknown, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.

Daniel Sobral (D)

UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugal.

Micaela Domingues (M)

Champalimaud Centre for the Unknown, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.

Mayra Martinez-Lopez (M)

Champalimaud Centre for the Unknown, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.

Miguel de Almeida Fuzeta (M)

Champalimaud Centre for the Unknown, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.

Carlos Silva (C)

Champalimaud Centre for the Unknown, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.

Ana Rita Grosso (AR)

UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugal.

Rita Fior (R)

Champalimaud Centre for the Unknown, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal. rita.fior@research.fchampalimaud.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH